2017 Cold Chain Outlook

The life sciences cold-chain logistics field, as 2017 begins to wind down, continues to expand and mutate as new technological and regulatory concerns come into play. While large parts of biopharma industry management assume that cold chain logistics is a […]

Read More

The under-regulated world of patient services

It’s axiomatic that the trend toward specialty pharmaceuticals is expanding the range of patient-oriented services that the pharma industry is involved in: the very definition of a specialty pharmaceutical includes ones that require patient support. This has also been one […]

Read More

CVS readies a set of outcomes-based contracts for its clients

While announcing its annual update of drugs (now around 36) to be excluded from its “Standard Control Formulary” in 2018, the industry-leading pharmacy benefit manager (PBM) is also hinting at another cost-control measure: outcomes-based contracting. Such programs have been occasionally entered […]

Read More